Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Aesthetic Injectables under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Aesthetic Injectables under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc
- Acro Biomedical Co Ltd
- Advanced Aesthetic Technologies Inc
- Aeon Astron Corporation
- Aesthetic Medical Device
- Allergan Aesthetics
- Almirall Ltd
- Beijing MeiYan KongJian Technology Co Ltd
- BioPlus Co Ltd
- Bioxis Pharmaceuticals
- BMG Pharma SpA
- Bmi Korea Co Ltd
- CellPraxis
- Celltrix AB
- Collplant Biotechnologies Ltd
- Dexlevo Inc
- Dongkook Pharmaceutical Co Ltd
- EternoGen Aesthetics LLC
- Fillmed Laboratoires
- G2GBIO Inc
- Galderma SA
- Genzyme Corp
- Hallura Ltd
- Histogen Inc
- Hugel Inc
- Innovia LLC
- inSoma Bio Inc
- Inventage Lab Inc
- Jinwoo Bio Co Ltd
- Juvenis Ltd
- Khorionyx SA
- Laboratoires Vivacy SAS
- LG Chem Ltd
- LifeSprout Inc
- Medytox Inc
- Merz North America Inc
- Mesoestetic Pharma Group SL
- Moma Therapeutics Inc
- N8 Medical LLC
- Oligo Medic Inc
- PB&B SA
- Peptron Inc
- PetVivo Holdings Inc
- Q-Med AB
- RepliCel Life Sciences Inc
- Samyang Biopharmaceuticals Corp
- Sebana Medical Ltd
- Shanghai Haohai Biological Technology Co Ltd
- Shin Poong Pharm Co Ltd
- Silk Medical Aesthetics Inc
- Sinclair Pharma Ltd
- Sofregen Medical Inc
- SunMax Biotechnology Co Ltd
- TEI Biosciences Inc
- Tempo Therapeutics Inc
- Teoxane SA
- Tetratherix Pty Ltd
- Tissueform Inc
- University of California Santa Barbara
- University of Missouri

